TRENDS IN PAEDIATRIC CANDIDEMIA: ITS PREVALENCE AND SPECIES DISTRIBUTION.
Main Article Content
Keywords
Paediatric, candidemia, chromogenic agar
Abstract
Background- Candidemia poses the greatest threat with a high fatality rate among children of all blood stream infections (BSI), Candidemia is defined as the presence of Candida species in the blood determined by at least one positive blood culture in patients with fever and signs of a blood stream infection (BSI). The present study aimed to demonstrate the prevalence of candidemia among children.
Methodology -
Study design- Prospective cross-sectional study
Study Centre- Microbiology Laboratory, Bundelkhand Medical College, Sagar, Madhya Pradesh.
Study duration- January to december 2022.
Methods and material- Microorganism were isolated from blood samples of children age group 0-10 years and identified via standard microbiological procedures. Chromogenic media was used to isolate and identify the Candida species.
Result- Among the 1022 paediatric blood cultures sent to the microbiology laboratory in 2022, 296 (29.1%) were positive for different microorganisms; with 49/296 (17.2%) positive for Candida.
Conclusion- The prevalence of candidemia was high, the fatality rate was alarming and non Candida albicans species were predominant.
References
2. Bajwa S, Kulshrestha A. Fungal infections in intensive care unit: challenges in diagnosis and management. Ann Med Health Sci Res. 2013;3:238. doi: 10.4103/2141-9248.113669 [DOI] [PMC free article] [PubMed] [Google Scholar]
3. Hesstvedt L, Gaustad P, Andersen CT, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21:938–945. doi: 10.1016/j.cmi.2015.06.008 [DOI] [PubMed] [Google Scholar]
4. Ericson EL, Klingspor L, Ullberg M, et al. Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/Alert FN blood culture vials for the detection of candidemia. Diagn Microbiol Infect Dis. 2012;73:153–156. doi: 10.1016/j.diagmicrobio.2012.02.020 [DOI] [PubMed] [Google Scholar]
5. Zaki SM, Denning DW. Serious fungal infections in Egypt. Eur J Clin Microbiol Infect Dis. 2017;36(6):971–974. doi: 10.1007/s10096-017-2929-4 [DOI] [PubMed] [Google Scholar]
6. Chow JK, Golan Y, Ruthazer R, et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis. 2008;46:1206–1213. doi: 10.1086/529435 [DOI] [PubMed] [Google Scholar]
7. Lyon GM, Karatela S, Sunay S. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48(4):1270–1275. doi: 10.1128/JCM.02363-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent problem. Clin Microbiol Rev. 2007;20(1):133–163. doi: 10.1128/CMR.00029-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
9. BioMérieux product list. 2012. Available from: www.bioMérieux.com. doi: 10.1094/PDIS-11-11-0999-PDN. Accessed July 2016. [DOI]
10. Oxoid product list. 2012. Available from: www.oxoid.com. doi: 10.1094/PDIS-11-11-0999-PDN. Accessed July 2016. [DOI]
11. Cheesbrough M. Microbiological tests In: Cheesbrough M, editor. District Laboratory Practice in Tropical Countries. 2nd ed. 2009. Cambridge University Press: Part II, Chapter (7). 1–266. [Google Scholar]
12. Lee SC, LO HJ, Fung CP, Lee N, See LC. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunolo Infect. 2009;42(2):148–153. [PubMed] [Google Scholar]
13. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012. (Document M27-S4). [Google Scholar]
14. Alastruey-Izquierdo A, Melhem MSC, Bonfietti LX, Rodriguez-Tudela JL. Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop Sao Paulo. 2015;57(19):57–64. doi: 10.1590/S0036-46652015000700011 [DOI] [PMC free article] [PubMed] [Google Scholar]
15. Fu J, Ding Y, Wei B, et al. Epidemiology of Candida albicans and non- C. albicans of neonatal candidemia at a tertiary care hospital in western China Journal List. BMC Infect Dis. 2017;17(1):329. doi: 10.1186/s12879-017-2757-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Hegazi M, Abdelkader A, Zaki M, El-Deek B. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children’s hospital in Egypt. J Infect Dev Ctries. 2014;8(5):624–634. doi: 10.3855/jidc.4186 [DOI] [PubMed] [Google Scholar]
17. Gupta P, Prateek S, Chatterjee B, Kotwal A, Singh AK, Mittal G. Prevalence of candidaemia in ICU in a tertiary care hospital in North India. Int J Curr Microbiol Sci. 2015;4(6):566–575. [Google Scholar]
18. Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011;27(1):163–205. doi: 10.1016/j.ccc.2010.11.002 [DOI] [PubMed] [Google Scholar]
19. Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011;30(8):664–668. doi: 10.1097/INF.0b013e318213da0f [DOI] [PubMed] [Google Scholar]
20. Rajendran RL, Sherry CJ, Nile A, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—scotland, 2012–2013. Clin Microbiol Infect. 2016;22(1):87–93. doi: 10.1016/j.cmi.2015.09.018 [DOI] [PMC free article] [PubMed] [Google Scholar]